MET and breast cancer: Interestingly, examination of NK2-induced signal transduction in cell culture demonstrated that NK2 was capable of activating both PI3K and p42/p44 MAPK in 32D cells expressing MET and in a breast cancer epithelial cell line, suggesting that these two pathways were not sufficient to induce proliferation in response to MET activation [86].